MiNK Therapeutics, Inc. (INKT) Description, Stock price, News & Info

#ThinkSabio Latest News

INKT – MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications